Type Public company Website reneuron.com Headquarters United Kingdom | Traded as LSE: RENE Founded 1997 | |
Industry Stem cell research & development Stock price RENE (LON) 2.38 GBX +0.03 (+1.49%)24 Mar, 4:24 PM GMT - Disclaimer | ||
Reneuron company presentation
ReNeuron is a UK-based stem cell research company whose shares are listed on the Alternative Investment Market. Its focus is on the development of stem-cell therapies targeting areas of poorly-met medical need, including peripheral arterial disease, strokes, and retinal diseases.
Contents
ReNeuron is currently testing the effects of neural stem cells on spinal cords for neuroregeneration. They are also testing the use of fetal stem cells on stroke patients.
Reneuron
References
ReNeuron Wikipedia(Text) CC BY-SA